• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米比亚公共卫生行动中的 HIV 耐药性早期预警指标。

HIV drug resistance early warning indicators in Namibia for public health action.

机构信息

Directorate of Special Programmes, Republic of Namibia Ministry of Health and Social Services, Windhoek, Namibia.

出版信息

PLoS One. 2013 Jun 7;8(6):e65653. doi: 10.1371/journal.pone.0065653. Print 2013.

DOI:10.1371/journal.pone.0065653
PMID:23762406
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3676318/
Abstract

BACKGROUND

HIV drug resistance (HIVDR) testing is not routinely available in many resource-limited settings, therefore antiretroviral therapy (ART) program and site factors known to be associated with emergence of HIVDR should be monitored to optimize the quality of patient care and minimize the emergence of preventable HIVDR.

METHODS

In 2010, Namibia selected five World Health Organization Early Warning Indicators (EWIs) and scaled-up monitoring from 9 to 33 ART sites: ART prescribing practices, Patients lost to follow-up (LTFU) at 12 months, Patients switched to a second-line regimen at 12 months, On-time antiretroviral (ARV) drug pick-up, and ARV drug-supply continuity.

RESULTS

Records allowed reporting on three of the five selected EWIs. 22 of 33 (67%) sites met the target of 100% initiated on appropriate first-line regimens. 17 of 33 (52%) sites met the target of ≤20% LTFU. 15 of 33 (45%) sites met the target of 0% switched to a second-line regimen.

CONCLUSIONS

EWI monitoring directly resulted in public health action which will optimize the quality of care, specifically the strengthening of ART record systems, engagement of ART sites, and operational research for improved adherence assessment and ART patient defaulter tracing.

摘要

背景

在许多资源有限的环境中,HIV 耐药性(HIVDR)检测并不常规提供,因此应监测与 HIVDR 出现相关的抗逆转录病毒治疗(ART)计划和地点因素,以优化患者护理质量并最大程度地减少可预防的 HIVDR 的出现。

方法

2010 年,纳米比亚选择了五个世界卫生组织早期预警指标(EWI),并将监测范围从 9 个扩大到 33 个 ART 点:ART 处方实践、12 个月时失访的患者、12 个月时转为二线方案的患者、按时取抗逆转录病毒(ARV)药物,以及 ARV 药物供应的连续性。

结果

33 个站点中的 22 个(67%)达到了 100%开始使用适当的一线方案的目标。33 个站点中的 17 个(52%)达到了失访率≤20%的目标。33 个站点中的 15 个(45%)达到了无患者转为二线方案的目标。

结论

EWI 监测直接导致了公共卫生行动,这将优化护理质量,特别是加强 ART 记录系统、参与 ART 站点,以及开展操作研究,以改善依从性评估和 ART 患者逃检者的追踪。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/507b/3676318/f29f30c67ee1/pone.0065653.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/507b/3676318/f29f30c67ee1/pone.0065653.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/507b/3676318/f29f30c67ee1/pone.0065653.g001.jpg

相似文献

1
HIV drug resistance early warning indicators in Namibia for public health action.纳米比亚公共卫生行动中的 HIV 耐药性早期预警指标。
PLoS One. 2013 Jun 7;8(6):e65653. doi: 10.1371/journal.pone.0065653. Print 2013.
2
Population-based monitoring of HIV drug resistance in Namibia with early warning indicators.纳米比亚基于人群的 HIV 耐药性监测及早期预警指标。
J Acquir Immune Defic Syndr. 2010 Dec;55(4):27-31. doi: 10.1097/QAI.0b013e3181f5376d.
3
Assessment of the World Health Organization's HIV Drug Resistance Early Warning Indicators in Main and Decentralized Outreach Antiretroviral Therapy Sites in Namibia.纳米比亚主要和分散式外展抗逆转录病毒治疗点的世界卫生组织艾滋病毒耐药性早期预警指标评估
PLoS One. 2016 Dec 1;11(12):e0166649. doi: 10.1371/journal.pone.0166649. eCollection 2016.
4
Declining trends in early warning indicators for HIV drug resistance in Cameroon from 2008-2010: lessons and challenges for low-resource settings.2008-2010 年喀麦隆 HIV 耐药性早期预警指标呈下降趋势:对资源匮乏环境的经验教训和挑战。
BMC Public Health. 2013 Apr 8;13:308. doi: 10.1186/1471-2458-13-308.
5
Early warning indicators for HIV drug resistance in Cameroon during the year 2010.2010 年期间喀麦隆的 HIV 耐药性早期预警指标。
PLoS One. 2012;7(5):e36777. doi: 10.1371/journal.pone.0036777. Epub 2012 May 17.
6
HIV drug resistance early warning indicators in namibia with updated World Health Organization guidance.纳米比亚的艾滋病毒耐药性早期预警指标及世界卫生组织的最新指南
PLoS One. 2014 Jul 2;9(7):e100539. doi: 10.1371/journal.pone.0100539. eCollection 2014.
7
An assessment of the relationship between the World Health Organization HIV drug resistance early warning indicators and HIV drug resistance acquisition.世界卫生组织艾滋病病毒耐药性早期预警指标与艾滋病病毒耐药性获得之间关系的评估。
HIV Med. 2017 May;18(5):342-353. doi: 10.1111/hiv.12435. Epub 2016 Oct 4.
8
Population-based monitoring of HIV drug resistance early warning indicators in Uganda: A nationally representative survey following revised WHO recommendations.乌干达基于人群的 HIV 耐药性早期预警指标监测:根据世卫组织修订建议进行的全国代表性调查。
PLoS One. 2020 Apr 14;15(4):e0230451. doi: 10.1371/journal.pone.0230451. eCollection 2020.
9
Early warning indicators for population-based monitoring of HIV drug resistance in 6 African countries.基于人群的 6 个非洲国家 HIV 耐药性监测的早期预警指标。
Clin Infect Dis. 2012 May;54 Suppl 4:S294-9. doi: 10.1093/cid/cir1015.
10
Monitoring HIV Drug Resistance Early Warning Indicators in Cameroon: A Study Following the Revised World Health Organization Recommendations.喀麦隆艾滋病毒耐药性早期预警指标监测:一项遵循世界卫生组织修订建议的研究
PLoS One. 2015 Jun 17;10(6):e0129210. doi: 10.1371/journal.pone.0129210. eCollection 2015.

引用本文的文献

1
Programme quality indicators of HIV drug resistance among adolescents in urban versus rural settings of the centre region of Cameroon.喀麦隆中部地区城乡环境下青少年艾滋病毒耐药性的项目质量指标
AIDS Res Ther. 2020 May 12;17(1):14. doi: 10.1186/s12981-020-00270-7.
2
Digital health technologies to support access to medicines and pharmaceutical services in the achievement of sustainable development goals.支持获取药品和制药服务以实现可持续发展目标的数字健康技术。
Digit Health. 2018 May 3;4:2055207618771407. doi: 10.1177/2055207618771407. eCollection 2018 Jan-Dec.
3
Assessment of the World Health Organization's HIV Drug Resistance Early Warning Indicators in Main and Decentralized Outreach Antiretroviral Therapy Sites in Namibia.

本文引用的文献

1
Medication possession ratio associated with short-term virologic response in individuals initiating antiretroviral therapy in Namibia.在纳米比亚,开始接受抗逆转录病毒治疗的个体的药物持有率与短期病毒学应答相关。
PLoS One. 2013;8(2):e56307. doi: 10.1371/journal.pone.0056307. Epub 2013 Feb 28.
2
Early warning indicators for HIV drug resistance in Cameroon during the year 2010.2010 年期间喀麦隆的 HIV 耐药性早期预警指标。
PLoS One. 2012;7(5):e36777. doi: 10.1371/journal.pone.0036777. Epub 2012 May 17.
3
Monitoring of early warning indicators for HIV drug resistance in antiretroviral therapy clinics in Zimbabwe.
纳米比亚主要和分散式外展抗逆转录病毒治疗点的世界卫生组织艾滋病毒耐药性早期预警指标评估
PLoS One. 2016 Dec 1;11(12):e0166649. doi: 10.1371/journal.pone.0166649. eCollection 2016.
4
Population-based surveillance of HIV drug resistance emerging on treatment and associated factors at sentinel antiretroviral therapy sites in Namibia.纳米比亚哨点抗逆转录病毒治疗点基于人群的HIV治疗中出现的耐药性及其相关因素监测。
J Acquir Immune Defic Syndr. 2015 Apr 1;68(4):463-71. doi: 10.1097/QAI.0000000000000509.
5
HIV drug resistance early warning indicators in namibia with updated World Health Organization guidance.纳米比亚的艾滋病毒耐药性早期预警指标及世界卫生组织的最新指南
PLoS One. 2014 Jul 2;9(7):e100539. doi: 10.1371/journal.pone.0100539. eCollection 2014.
津巴布韦抗逆转录病毒治疗诊所中 HIV 耐药性早期预警指标的监测。
Clin Infect Dis. 2012 May;54 Suppl 4(Suppl 4):S313-6. doi: 10.1093/cid/cir1014.
4
Experience in piloting HIV drug resistance early warning indicators to improve the antiretroviral program in Papua New Guinea.在巴布亚新几内亚推行 HIV 耐药性早期预警指标方面的经验,以改善抗逆转录病毒方案。
Clin Infect Dis. 2012 May;54 Suppl 4:S303-5. doi: 10.1093/cid/cir994.
5
Monitoring HIV drug resistance using early warning indicators in China: results from a pilot survey conducted in 2008.利用早期预警指标监测中国的 HIV 耐药性:2008 年试点调查结果。
Clin Infect Dis. 2012 May;54 Suppl 4:S300-2. doi: 10.1093/cid/cir1018.
6
Early warning indicators for population-based monitoring of HIV drug resistance in 6 African countries.基于人群的 6 个非洲国家 HIV 耐药性监测的早期预警指标。
Clin Infect Dis. 2012 May;54 Suppl 4:S294-9. doi: 10.1093/cid/cir1015.
7
HIV drug resistance early warning indicators in cohorts of individuals starting antiretroviral therapy between 2004 and 2009: World Health Organization global report from 50 countries.2004 年至 2009 年间开始接受抗逆转录病毒治疗的个体队列中的 HIV 耐药性早期预警指标:来自 50 个国家的世界卫生组织全球报告。
Clin Infect Dis. 2012 May;54 Suppl 4(Suppl 4):S280-9. doi: 10.1093/cid/cis207.
8
Assessments of HIV drug resistance mutations in resource-limited settings.资源有限环境下的HIV耐药性突变评估。
Clin Infect Dis. 2011 Apr 15;52(8):1058-60. doi: 10.1093/cid/cir093.
9
Population-based monitoring of HIV drug resistance in Namibia with early warning indicators.纳米比亚基于人群的 HIV 耐药性监测及早期预警指标。
J Acquir Immune Defic Syndr. 2010 Dec;55(4):27-31. doi: 10.1097/QAI.0b013e3181f5376d.
10
Transportation costs impede sustained adherence and access to HAART in a clinic population in southwestern Uganda: a qualitative study.乌干达西南部一个诊所人群中,运输成本妨碍了持续的抗逆转录病毒治疗(HAART)依从性和可及性:一项定性研究。
AIDS Behav. 2010 Aug;14(4):778-84. doi: 10.1007/s10461-009-9533-2. Epub 2009 Mar 13.